Drawing for PHARMACAPS

USPTO serial 77721772

PHARMACAPS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
WHITTAKER BROWN, TRACY
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHARMACAPS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005soft gelatin and non-animal film encapsulations and hard core enrobements for various pharmaceutical preparations, namely, aids related complex (ARC) therapeutic agents, antidiarrheals, antihistamines, analgesics, antacids, antiflatulents, antifungals, antiemetics, antipyretics, antiarthritics, antiinfectives for the treatment of fungal and viral infections, antinauseants, antiobesity preparations, cancer therapy preparations, calcium supplements, cough and cold preparations, digestants, diuretics, dermatologicals for the treatment of skin disorders, hormones, histamine H2 receptor antagonists, hypnotics, hypolipidemics, laxatives, psychotherapeutics, sedatives and sleep aids; soft gelatin and non-animal film encapsulations and hard core enrobements for cardiovascular agents, namely, calcium channel blockers for heart disease; soft gelatin and non-animal film encapsulations and hard core enrobements for gastrointestinal preparations, namely, preparations for the treatment of flatulence and constipation; soft gelatin and non-animal film encapsulations and hard core enrobements for musculoskeletal preparations, namely, calcium, vitamin D and osteoporosis treatments; soft gelatin and non-animal film encapsulations and hard core enrobements for transplant and immunosuppressant preparations, namely, cyclosporine; soft gelatin and non-animal film encapsulations and hard core enrobements for pharmaceutical preparations for the treatment of disorders of the central nervous system, the respiratory system, for the treatment of sexual dysfunction and for the treatment of neurological disorders and seizures; soft gelatin and non-animal film encapsulations and hard core enrobements for natural medicine preparations, namely, herbal supplements; soft gelatin and non-animal film encapsulations and hard core enrobements for vitamin, mineral and nutritional supplements; pharmaceutical preparations, namely, AIDS related complex (ARC) therapeutic agents, antidiarrheals, antihistamines, analgesics, antacids, antiflatulents, antifungals, antiemetics, antipyretics, antiarthritics, antiinfectives for the treatment of fungal and viral infections, antinauseants, antiobesity preparations, cancer therapy preparations, calcium supplements, cough and cold preparations, digestants, diuretics, dermatologicals for the treatment of skin disorders, hormones, histamine H2 receptor antagonists, hypnotics, hypolipidemics, laxatives, psychotherapeutics, sedatives and sleep aids; cardiovascular agents, namely, calcium channel blockers for heart disease; gastrointestinal products, namely, preparations for the treatment of flatulence and constipation; musculoskeletal preparations, namely, calcium, vitamin D and osteoporosis treatments; transplant and immunosuppressant preparations, namely, cyclosporine; pharmaceutical preparations for the treatment of disorders of the central nervous system, the respiratory system, for the treatment of sexual dysfunction and for the treatment of neurological disorders and seizures; natural medicine products, namely, herbal supplements; vitamin, mineral and nutritional supplementsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 30, 2014ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Aug 5, 2013MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 5, 2013ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 27, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 26, 2012ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 26, 2012EX5GSOU EXTENSION 5 GRANTED
Dec 20, 2012EXT5SOU EXTENSION 5 FILED
Dec 20, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 7, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 6, 2012EX4GSOU EXTENSION 4 GRANTED
Jul 3, 2012EXT4SOU EXTENSION 4 FILED
Jul 3, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 12, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 11, 2012EX3GSOU EXTENSION 3 GRANTED
Jan 4, 2012EXT3SOU EXTENSION 3 FILED
Jan 4, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 12, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 11, 2011EX2GSOU EXTENSION 2 GRANTED
Jul 7, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 6, 2011EXT2SOU EXTENSION 2 FILED
Jul 6, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 6, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 4, 2011EX1GSOU EXTENSION 1 GRANTED
Jan 4, 2011EXT1SOU EXTENSION 1 FILED
Jan 4, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 6, 2010NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 11, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 11, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 7, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 7, 2010ALIEASSIGNED TO LIE
Mar 20, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 19, 2010XAECEXAMINER'S AMENDMENT ENTERED
Mar 19, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 19, 2010GNEAEXAMINERS AMENDMENT E-MAILED
Mar 19, 2010CNEAEXAMINERS AMENDMENT -WRITTEN
Dec 30, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 30, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 30, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 1, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 23, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 23, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 23, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 11, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 11, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 11, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 7, 2009DOCKASSIGNED TO EXAMINER
Apr 29, 2009MPMKNOTICE OF PSEUDO MARK MAILED
Apr 28, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2009NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance